FST, follistatin, 10468

N. diseases: 182; N. variants: 7
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast
0.370 AlteredExpression disease BEFREE FST expression was examined using reverse transcription polymerase chain reaction (RT-PCR), real-time quantitative polymerase chain reaction (qPCR) and immunohistochemistry in a cohort of breast cancer samples. 28647698 2018
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast
0.370 Biomarker disease BEFREE In summary, MCF7 cells show high chemosensitivity to Follistatin and especially GDF8 and both proteins might serve as targets to improve systemic treatment in breast cancer. 29156385 2018
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast
0.370 Biomarker disease BEFREE Despite experimental evidence that follistatin can modulate the breast cancer cell cycle, the clinical significance of follistatin expression in these tumors is unknown. 27389553 2018
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.370 AlteredExpression disease BEFREE FST expression was examined using reverse transcription polymerase chain reaction (RT-PCR), real-time quantitative polymerase chain reaction (qPCR) and immunohistochemistry in a cohort of breast cancer samples. 28647698 2018
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.370 Biomarker disease BEFREE In summary, MCF7 cells show high chemosensitivity to Follistatin and especially GDF8 and both proteins might serve as targets to improve systemic treatment in breast cancer. 29156385 2018
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.370 Biomarker disease BEFREE Despite experimental evidence that follistatin can modulate the breast cancer cell cycle, the clinical significance of follistatin expression in these tumors is unknown. 27389553 2018
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast
0.370 AlteredExpression disease BEFREE Examination of multiple breast cancer datasets revealed that FST expression is reduced in breast cancers compared with normal tissue and that low FST expression predicts increased metastasis and reduced overall survival. 28583174 2017
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.370 AlteredExpression disease BEFREE Examination of multiple breast cancer datasets revealed that FST expression is reduced in breast cancers compared with normal tissue and that low FST expression predicts increased metastasis and reduced overall survival. 28583174 2017
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast
0.370 Biomarker disease BEFREE Therefore, we concluded that FST and KLK6 may have significance in breast cancer detection. 27168011 2016
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.370 Biomarker disease BEFREE Therefore, we concluded that FST and KLK6 may have significance in breast cancer detection. 27168011 2016
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast
0.370 Biomarker disease BEFREE Overexpressed ERRβ induced FST-mediated apoptosis in breast cancer cells, and E-cadherin expression was also enhanced through upregulation of FST. 24667650 2014
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.370 Biomarker disease BEFREE Overexpressed ERRβ induced FST-mediated apoptosis in breast cancer cells, and E-cadherin expression was also enhanced through upregulation of FST. 24667650 2014
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast
0.370 AlteredExpression disease BEFREE As activin displays an anti-proliferative effect in human mammary cells, the present findings indicate that an increased FST and FLRG expression in breast proliferative diseases might counteract the anti-proliferative effects of activin in human breast cancer. 19740438 2009
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.370 AlteredExpression disease BEFREE As activin displays an anti-proliferative effect in human mammary cells, the present findings indicate that an increased FST and FLRG expression in breast proliferative diseases might counteract the anti-proliferative effects of activin in human breast cancer. 19740438 2009
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast
0.370 Biomarker disease CTD_human ERE-independent ERalpha target genes differentially expressed in human breast tumors. 16298037 2005
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.370 Biomarker disease CTD_human ERE-independent ERalpha target genes differentially expressed in human breast tumors. 16298037 2005
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.330 AlteredExpression disease BEFREE FST is differentially expressed in human tissues and aberrant expression has been observed in a variety of solid tumours, including gonadal, gastric and lung cancer, hepatocellular carcinoma, basal cell carcinoma and melanoma. 27807065 2017
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.330 Biomarker disease CTD_human Discrimination of tumorigenic triazole conazoles from phenobarbital by transcriptional analyses of mouse liver gene expression. 19363144 2009
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.330 Biomarker disease BEFREE We conducted a cross sectional study assessing the value of these serum proteins, as well a novel candidate biomarker -follistatin - in patients with HCC arising on a background of ALD or NAFLD. 18638391 2008
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.330 Biomarker disease CTD_human Follistatin expression was also observed in cell lines derived from human hepatocellular carcinomas. 12203361 2002
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.330 AlteredExpression disease BEFREE Follistatin expression was also observed in cell lines derived from human hepatocellular carcinomas. 12203361 2002
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.320 Biomarker group BEFREE Follistatin Expression in Human Invasive Breast Tumors: Pathologic and Clinical Associations. 27389553 2018
CUI: C4552766
Disease: Miscarriage
Miscarriage
0.320 AlteredExpression disease BEFREE In humans, FST is up-regulated in the decidua during early pregnancy, and women with recurrent miscarriage have lower endometrial expression of FST during the luteal phase. 28559342 2017
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.320 Biomarker group BEFREE In order to establish if these activin binding proteins are involved in breast tumor progression, the present study evaluated follistatin and FLRG pattern of mRNA and protein expression in normal human breast tissue and in different breast proliferative diseases. 19740438 2009
CUI: C4552766
Disease: Miscarriage
Miscarriage
0.320 Biomarker disease CTD_human Gene expression in cultured endometrium from women with different outcomes following IVF. 18539642 2008